Cargando…
Ibandronate: The loading dose concept in the treatment of metastatic bone pain
BACKGROUND/AIM: Severe bone pain is experienced by 60–80% of patients with metastatic bone disease, and has a profound impact on quality of life. Therefore, effective pain relief is an important goal in managing metastatic bone disease. Orthopedic surgeons are often challenged with patients presenti...
Autores principales: | Maier, Gerrit Steffen, Eberhardt, Christian, Kurth, Andreas Alois |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782017/ https://www.ncbi.nlm.nih.gov/pubmed/26998420 http://dx.doi.org/10.1016/j.jbo.2015.11.001 |
Ejemplares similares
-
Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 Trial
por: Brouns, Anita J. W. M., et al.
Publicado: (2020) -
Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia.
por: Ralston, S. H., et al.
Publicado: (1997) -
Use of ibandronate in the prevention of skeletal events in metastatic breast cancer
por: Devitt, Bianca, et al.
Publicado: (2008) -
Effects of zoledronic acid and ibandronate in the treatment of cancer pain in rats with lung cancer combined with bone metastases
por: Wang, Gengshen, et al.
Publicado: (2018) -
Ibandronate to treat skeletal-related events and bone pain in metastatic bone disease or multiple myeloma: a meta-analysis of randomised clinical trials
por: Geng, Chun-Jing, et al.
Publicado: (2015)